Australian Natural Therapeutics Group is considering raising money to fund a 500 per cent increase in cannabis production as ...

Aurora Cannabis (TSX:ACB) is expanding its pastille offerings in Australia, marking a significant step in the company’s move to diversify its range of medical cannabis products ・This expansion aims to ...

New costings estimate that legalising cannabis could add $700 million a year to the federal bottom line, but that number is ...

As access to medical cannabis continues to expand, patients have more choices than ever before when it comes to finding a ...

Australia, Germany, the UK, Poland, and elsewhere. Now, on a TTM basis, the company produces roughly $223 million in revenue. More than 70% of this is from medical cannabis products, with the ...

Aurora Cannabis (ACB) has announced today the company’s extended pastille offerings in Australia ... a diverse range of high-quality, premium medical cannabis products to meet their various ...